PB

Palak Bhagirath Pandya

Active Director Director DIN 09077733
DIN 09077733 First appointment Feb 2021 Primary industry Travel and Hospitality
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Palak Bhagirath Pandya

Data last updated:

Palak Bhagirath Pandya is a Director at Megan Lifesciences Private Limited (since 2021). The company operates in Travel and Hospitality.

DIN 09077733
Primary Designation Director
Industry Travel and Hospitality
First Appointment 23 Feb 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Megan Lifesciences Private Limited U24299GJ2021PTC120506
Director23 Feb 20212021Active

Directorship timeline

Open interactive timeline →
Megan Lifesciences Private Limited
Premium access

Shareholding and investment profile for Palak Bhagirath Pandya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Palak Bhagirath Pandya

Palak Bhagirath Pandya currently holds 1 directorship: Megan Lifesciences Private Limited (Director, since 23 Feb 2021).

Palak Bhagirath Pandya was first appointed on 23 Feb 2021 as Director at Megan Lifesciences Private Limited.

The current boards of Palak Bhagirath Pandya's companies include Bhagirath Shankarlal Pandya (Megan Lifesciences Private Limited), Hirjibhai Dargabhai Patel (Megan Lifesciences Private Limited), Pankajkumar Ramanbhai Patel (Megan Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available